Progenics Pharma (PGNX) Surges Over 20% as FDA Approval Oral RELISTOR
Tweet Send to a Friend
Progenics Pharma (NASDAQ: PGNX) is ramping 21% in pre-open trade Wednesday after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
